© CellRev CellRev, a UK company producing proprietary media additives to optimise cell manufacturing, has ceased trading. In a LinkedIn statement, CEO Chris Green explained that the company had not been able to deliver commercial milestones quickly enough to secure Series A funding. Despite this, he noted that CellRev had achieved several goals since it was founded in 2018 as a spinout from Newcastle University. These included developing a continuous adherent cell ... more
